From Diagnostics to Therapy: The Rising Role of Non-IgG Antibodies
  Over the past few decades, monoclonal antibodies have become some of the most successful biotechnology drugs, particularly in hematology, oncology, autoimmune disorders, and infectious diseases. While IgG antibodies dominate current cancer therapies, non-IgG antibodies such as IgA, IgE, and IgY are gaining attention for their unique biological properties and therapeutic potential. These...
0 Kommentare 0 Geteilt 91 Ansichten 0 Bewertungen